GO:0051192 | prosthetic group binding | 8.2% (5/61) | 9.11 | 0.0 | 0.0 |
GO:0140414 | phosphopantetheine-dependent carrier activity | 8.2% (5/61) | 9.11 | 0.0 | 0.0 |
GO:0000036 | acyl carrier activity | 8.2% (5/61) | 9.11 | 0.0 | 0.0 |
GO:0044620 | ACP phosphopantetheine attachment site binding | 8.2% (5/61) | 9.11 | 0.0 | 0.0 |
GO:0016297 | acyl-[acyl-carrier-protein] hydrolase activity | 8.2% (5/61) | 9.46 | 0.0 | 0.0 |
GO:0016790 | thiolester hydrolase activity | 8.2% (5/61) | 7.1 | 0.0 | 0.0 |
GO:0140104 | molecular carrier activity | 8.2% (5/61) | 6.29 | 0.0 | 0.0 |
GO:0003959 | NADPH dehydrogenase activity | 4.92% (3/61) | 9.12 | 0.0 | 1e-06 |
GO:0006633 | fatty acid biosynthetic process | 8.2% (5/61) | 5.87 | 0.0 | 1e-06 |
GO:0072330 | monocarboxylic acid biosynthetic process | 8.2% (5/61) | 5.58 | 0.0 | 3e-06 |
GO:0006631 | fatty acid metabolic process | 8.2% (5/61) | 4.81 | 1e-06 | 3.3e-05 |
GO:0048200 | Golgi transport vesicle coating | 3.28% (2/61) | 9.94 | 2e-06 | 4.6e-05 |
GO:0048205 | COPI coating of Golgi vesicle | 3.28% (2/61) | 9.94 | 2e-06 | 4.6e-05 |
GO:0032787 | monocarboxylic acid metabolic process | 9.84% (6/61) | 4.05 | 2e-06 | 5.1e-05 |
GO:0009733 | response to auxin | 4.92% (3/61) | 6.92 | 2e-06 | 5.2e-05 |
GO:0005515 | protein binding | 26.23% (16/61) | 1.81 | 8e-06 | 0.000157 |
GO:0046394 | carboxylic acid biosynthetic process | 8.2% (5/61) | 3.97 | 1.8e-05 | 0.000331 |
GO:0016053 | organic acid biosynthetic process | 8.2% (5/61) | 3.97 | 1.8e-05 | 0.000331 |
GO:0006901 | vesicle coating | 3.28% (2/61) | 8.12 | 2.5e-05 | 0.000438 |
GO:0008150 | biological_process | 52.46% (32/61) | 0.92 | 4.2e-05 | 0.000699 |
GO:0003674 | molecular_function | 60.66% (37/61) | 0.78 | 5e-05 | 0.000718 |
GO:0005488 | binding | 45.9% (28/61) | 1.02 | 4.8e-05 | 0.000727 |
GO:0050794 | regulation of cellular process | 19.67% (12/61) | 1.96 | 4.6e-05 | 0.00073 |
GO:0050789 | regulation of biological process | 19.67% (12/61) | 1.89 | 7.4e-05 | 0.000946 |
GO:0017119 | Golgi transport complex | 3.28% (2/61) | 7.35 | 7.3e-05 | 0.00097 |
GO:2001141 | regulation of RNA biosynthetic process | 13.11% (8/61) | 2.49 | 8.6e-05 | 0.000989 |
GO:0006355 | regulation of DNA-templated transcription | 13.11% (8/61) | 2.49 | 8.6e-05 | 0.000989 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 4.92% (3/61) | 5.26 | 7.2e-05 | 0.000991 |
GO:0016050 | vesicle organization | 4.92% (3/61) | 5.19 | 8.3e-05 | 0.001026 |
GO:0044283 | small molecule biosynthetic process | 8.2% (5/61) | 3.42 | 0.000111 | 0.001229 |
GO:0051252 | regulation of RNA metabolic process | 13.11% (8/61) | 2.42 | 0.000122 | 0.001304 |
GO:0044255 | cellular lipid metabolic process | 9.84% (6/61) | 2.95 | 0.000127 | 0.00132 |
GO:0065007 | biological regulation | 19.67% (12/61) | 1.79 | 0.000145 | 0.001456 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 13.11% (8/61) | 2.36 | 0.000159 | 0.001556 |
GO:0008610 | lipid biosynthetic process | 8.2% (5/61) | 3.28 | 0.000173 | 0.001641 |
GO:0009725 | response to hormone | 4.92% (3/61) | 4.73 | 0.000209 | 0.001931 |
GO:0006082 | organic acid metabolic process | 9.84% (6/61) | 2.75 | 0.000271 | 0.00225 |
GO:0043436 | oxoacid metabolic process | 9.84% (6/61) | 2.75 | 0.00027 | 0.002298 |
GO:0009719 | response to endogenous stimulus | 4.92% (3/61) | 4.57 | 0.000293 | 0.002313 |
GO:0043227 | membrane-bounded organelle | 21.31% (13/61) | 1.59 | 0.000286 | 0.002313 |
GO:0019752 | carboxylic acid metabolic process | 9.84% (6/61) | 2.76 | 0.000266 | 0.002323 |
GO:0043231 | intracellular membrane-bounded organelle | 21.31% (13/61) | 1.6 | 0.000266 | 0.002383 |
GO:0051171 | regulation of nitrogen compound metabolic process | 13.11% (8/61) | 2.18 | 0.000368 | 0.00284 |
GO:0080090 | regulation of primary metabolic process | 13.11% (8/61) | 2.17 | 0.000392 | 0.002955 |
GO:0008330 | protein tyrosine/threonine phosphatase activity | 1.64% (1/61) | 10.68 | 0.000609 | 0.004043 |
GO:0033550 | MAP kinase tyrosine phosphatase activity | 1.64% (1/61) | 10.68 | 0.000609 | 0.004043 |
GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity | 1.64% (1/61) | 10.68 | 0.000609 | 0.004043 |
GO:0010468 | regulation of gene expression | 13.11% (8/61) | 2.09 | 0.000561 | 0.004138 |
GO:0006629 | lipid metabolic process | 9.84% (6/61) | 2.54 | 0.000588 | 0.004153 |
GO:0009889 | regulation of biosynthetic process | 13.11% (8/61) | 2.05 | 0.000661 | 0.004222 |
GO:0010556 | regulation of macromolecule biosynthetic process | 13.11% (8/61) | 2.08 | 0.000586 | 0.004231 |
GO:0031326 | regulation of cellular biosynthetic process | 13.11% (8/61) | 2.05 | 0.000658 | 0.004284 |
GO:0016788 | hydrolase activity, acting on ester bonds | 9.84% (6/61) | 2.43 | 0.000866 | 0.005426 |
GO:0043226 | organelle | 21.31% (13/61) | 1.39 | 0.001106 | 0.006444 |
GO:0060255 | regulation of macromolecule metabolic process | 13.11% (8/61) | 1.95 | 0.001055 | 0.006486 |
GO:0043229 | intracellular organelle | 21.31% (13/61) | 1.39 | 0.001105 | 0.006553 |
GO:0031323 | regulation of cellular metabolic process | 13.11% (8/61) | 1.94 | 0.001096 | 0.006619 |
GO:0019222 | regulation of metabolic process | 13.11% (8/61) | 1.89 | 0.001341 | 0.007673 |
GO:0003700 | DNA-binding transcription factor activity | 8.2% (5/61) | 2.61 | 0.00139 | 0.00782 |
GO:0016192 | vesicle-mediated transport | 6.56% (4/61) | 3.0 | 0.001618 | 0.008953 |
GO:0010033 | response to organic substance | 4.92% (3/61) | 3.69 | 0.001676 | 0.009123 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 3.28% (2/61) | 4.96 | 0.001951 | 0.01045 |
GO:0006897 | endocytosis | 3.28% (2/61) | 4.77 | 0.002531 | 0.013335 |
GO:0140110 | transcription regulator activity | 8.2% (5/61) | 2.36 | 0.002967 | 0.015393 |
GO:0044281 | small molecule metabolic process | 9.84% (6/61) | 2.05 | 0.003266 | 0.016184 |
GO:0033549 | MAP kinase phosphatase activity | 1.64% (1/61) | 8.27 | 0.003243 | 0.016315 |
GO:0043409 | negative regulation of MAPK cascade | 1.64% (1/61) | 8.27 | 0.003243 | 0.016315 |
GO:0043565 | sequence-specific DNA binding | 6.56% (4/61) | 2.7 | 0.003428 | 0.016495 |
GO:0042221 | response to chemical | 4.92% (3/61) | 3.33 | 0.003411 | 0.016653 |
GO:0098657 | import into cell | 3.28% (2/61) | 4.39 | 0.004216 | 0.019997 |
GO:0009959 | negative gravitropism | 1.64% (1/61) | 7.62 | 0.005063 | 0.023675 |
GO:0043408 | regulation of MAPK cascade | 1.64% (1/61) | 7.22 | 0.006678 | 0.030371 |
GO:0005773 | vacuole | 3.28% (2/61) | 4.05 | 0.006604 | 0.030451 |
GO:0099023 | vesicle tethering complex | 3.28% (2/61) | 4.0 | 0.007049 | 0.031626 |
GO:0005634 | nucleus | 11.48% (7/61) | 1.63 | 0.007176 | 0.031766 |
GO:1902532 | negative regulation of intracellular signal transduction | 1.64% (1/61) | 6.98 | 0.007887 | 0.034455 |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.28% (2/61) | 3.91 | 0.008003 | 0.034508 |
GO:0004340 | glucokinase activity | 1.64% (1/61) | 6.87 | 0.008492 | 0.036143 |
GO:0033500 | carbohydrate homeostasis | 1.64% (1/61) | 6.73 | 0.009397 | 0.037141 |
GO:0001678 | intracellular glucose homeostasis | 1.64% (1/61) | 6.73 | 0.009397 | 0.037141 |
GO:0042593 | glucose homeostasis | 1.64% (1/61) | 6.73 | 0.009397 | 0.037141 |
GO:0005536 | glucose binding | 1.64% (1/61) | 6.73 | 0.009397 | 0.037141 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 3.28% (2/61) | 3.82 | 0.009024 | 0.037452 |
GO:0004725 | protein tyrosine phosphatase activity | 1.64% (1/61) | 6.79 | 0.008995 | 0.037801 |
GO:0044249 | cellular biosynthetic process | 9.84% (6/61) | 1.71 | 0.010081 | 0.039376 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 1.64% (1/61) | 6.59 | 0.010302 | 0.03977 |
GO:0006996 | organelle organization | 6.56% (4/61) | 2.21 | 0.010971 | 0.040027 |
GO:0009629 | response to gravity | 1.64% (1/61) | 6.51 | 0.010905 | 0.040226 |
GO:0009630 | gravitropism | 1.64% (1/61) | 6.51 | 0.010905 | 0.040226 |
GO:0008865 | fructokinase activity | 1.64% (1/61) | 6.51 | 0.010905 | 0.040226 |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.28% (2/61) | 3.68 | 0.010866 | 0.041466 |
GO:0004396 | hexokinase activity | 1.64% (1/61) | 6.4 | 0.011808 | 0.042612 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.28% (2/61) | 3.59 | 0.012202 | 0.043559 |
GO:0046835 | carbohydrate phosphorylation | 1.64% (1/61) | 6.32 | 0.01241 | 0.043831 |
GO:0004575 | sucrose alpha-glucosidase activity | 1.64% (1/61) | 6.23 | 0.013212 | 0.045691 |
GO:0005987 | sucrose catabolic process | 1.64% (1/61) | 6.23 | 0.013212 | 0.045691 |
GO:0033926 | glycopeptide alpha-N-acetylgalactosaminidase activity | 1.64% (1/61) | 6.2 | 0.013512 | 0.046248 |
GO:0009968 | negative regulation of signal transduction | 1.64% (1/61) | 6.05 | 0.015014 | 0.047928 |
GO:0010648 | negative regulation of cell communication | 1.64% (1/61) | 6.05 | 0.015014 | 0.047928 |
GO:0023057 | negative regulation of signaling | 1.64% (1/61) | 6.05 | 0.015014 | 0.047928 |
GO:1901576 | organic substance biosynthetic process | 9.84% (6/61) | 1.59 | 0.014752 | 0.048978 |
GO:0005905 | clathrin-coated pit | 1.64% (1/61) | 6.06 | 0.014914 | 0.049023 |
GO:0004564 | beta-fructofuranosidase activity | 1.64% (1/61) | 6.08 | 0.014714 | 0.049342 |
GO:0090599 | alpha-glucosidase activity | 1.64% (1/61) | 6.09 | 0.014613 | 0.049507 |